PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape. [PDF]
Skyles T +17 more
europepmc +1 more source
Quantitative Comparison of SPECT and PET Performance for Clinical Theranostic Applications. [PDF]
Salerno I +10 more
europepmc +1 more source
Identification, Characterization, and Optimization of Integrin αvβ₆-Targeting Peptides from a One-Bead One-Compound (OBOC) Library: Towards the Development of Positron Emission Tomography (PET) Imaging Agents. [PDF]
Tang YSC +3 more
europepmc +1 more source
The Final Frontier: Toward Transformative Insights into the Pathophysiologic Adaptations to Microgravity with Molecular Imaging. [PDF]
Jadvar H.
europepmc +1 more source
PET-Derived Renal Perfusion Provides a Window Into Cardiorenal Risk Beyond Filtration. [PDF]
Patel KK, Dilsizian V.
europepmc +1 more source
Boron Neutron Capture Therapy: A Technology-Driven Renaissance. [PDF]
Zheng D +8 more
europepmc +1 more source
PSMA-Based Radiopharmaceuticals in Prostate Cancer Theranostics: Imaging, Clinical Advances, and Future Directions. [PDF]
Civelek AC.
europepmc +1 more source
<sup>18</sup>F-FDG PET/CT findings of unknown primary cancer with occult lesions but large metastases. [PDF]
Yao Y.
europepmc +1 more source
Immuno-imaging in solid organ transplantation. [PDF]
Maas RJF +7 more
europepmc +1 more source
Clinical amyloid and tau positron emission tomography imaging in Alzheimer's disease: image interpretation in the era of anti-amyloid therapies. [PDF]
Mathoux G +4 more
europepmc +1 more source

